APPLICATION
ANDA062646
TYPE
ANDA
ORIGINAL APPROVAL
1992-06-30
LATEST ACTION
2000-07-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
ULTRAGRIS-330Discontinued
GRISEOFULVIN, ULTRAMICROCRYSTALLINE 330MG · TABLET · ORAL
Approval history
2000-07-07Manufacturing (CMC) · Supplement 2AP
1994-05-11Manufacturing (CMC) · Supplement 1AP
1992-06-30OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.